Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

OX40-targeted therapies may help treat skin diseases by reducing inflammation and balancing immune responses.

Patients were very satisfied with hair regrowth after taking ritlecitinib for alopecia areata.

Hair regrowth improved, but quality of life did not.

New near-infrared OLED emitters are more efficient, especially platinum(II) complexes, and have promising applications like hair growth treatment.

EGFR inhibitors for lung cancer can cause severe skin issues.

ZD1839 can cause skin issues like acne and hair changes.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

The method reliably profiles eicosanoids and shows epitestosterone reduces their levels, similar to common anti-inflammatory drugs.

The top research priorities for congenital ichthyosis include long-term side effects of oral retinoids, best topical treatments, and treatments for itch and hair loss.

Arsenic trioxide effectively treats APL, improving survival rates despite its toxicity.

AIRE protein, defective in APECED patients, is found in skin and hair cells and interacts with cytokeratin 17.

BBR-SA nanomedicine is a safe and effective treatment for breast cancer.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

Erlotinib can cause hair loss and texture changes.

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.

Using old drugs for new uses can help treat rare immune deficiencies.

Including ineffective or unsafe doses in reviews can lead to misleading conclusions about alopecia areata treatments.

EGFR inhibitors can cause unusual localized hair growth.

Dutasteride is more effective than finasteride for hair growth, and pregabalin effectively treats neuropathic pain.

Lower irisin levels in the blood may indicate more severe acne.

TYK2 inhibitors show promise for treating cancer and autoimmune disorders.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Advanced therapy medicinal products show promise for vitiligo treatment with fewer side effects, but affordability is a challenge.

CRET therapy affects inflammation in skin cells by changing cytokine levels and activating certain proteins.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Nanotechnology shows promise for better drug delivery and cancer treatment.